Medtronic buys Canada's CryoCath for $380m
This article was originally published in Clinica
Executive Summary
Medtronic is looking to expand its cardiovascular surgery offering, specifically in the atrial fibrillation (AF) sector, by agreeing to acquire Canadian cryoablation specialist CryoCath Technologies for Can$400m ($380m).